Emvision Medical Devices Ltd (EMV) — Capital Reinvestment Ratio

Latest as of December 2022: 0.01x

Emvision Medical Devices Ltd (EMV) has a Capital Reinvestment Ratio of 0.01x as of December 2022, meaning it reinvests 0% of its operating cash flow (AU$2.92 Million) in capital expenditures (AU$20.23K). Check how tangible is Emvision Medical Devices Ltd's equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

AU$2.92 Million
AUD

Capital Expenditures

AU$20.23K
AUD

Data as of

Dec 2022
Most recent filing

Emvision Medical Devices Ltd Capital Reinvestment Ratio (2023–2023)

This chart tracks Emvision Medical Devices Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see EMV cash flow metrics.

Annual Capital Reinvestment Ratio for Emvision Medical Devices Ltd (2023–2023)

Year-by-year Capital Reinvestment Ratio for Emvision Medical Devices Ltd from 2023 to 2023. See Emvision Medical Devices Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2023 0.22x AU$834.15K AU$187.29K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow